RTW Investments, LP and its Managing Partner Roderick Wong filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 5,905,426 shares of Solid Biosciences Inc. common stock as of September 30, 2026.

Key Highlights

  • Reporting persons: RTW Investments, LP, a Delaware limited partnership, and Roderick Wong, M.D., its Managing Partner and Chief Investment Officer, filed jointly.
  • Shares reported: 5,905,426 shares of Solid Biosciences Inc. common stock, $0.001 par value, are reported as beneficially owned by each reporting person.
  • Percent of class: The 5,905,426 shares represent 5.5% of the class, calculated based on 107,225,238 shares outstanding as of August 4, 2026.
  • Voting and dispositive power: Both reporting persons report zero sole voting or dispositive power; shared voting and shared dispositive power each stand at 5,905,426 shares.
  • Triggering event date: The date of event requiring the filing is listed as September 30, 2026.
  • Shares held through funds: According to the filing, the shares are directly held by the RTW Funds, with RTW Investments serving as investment adviser to those funds.

RTW Investments and Roderick Wong Disclose Shared Beneficial Ownership in Solid Biosciences

According to the Schedule 13G filed November 16, 2026, RTW Investments, LP and Roderick Wong, M.D. each report beneficial ownership of 5,905,426 shares of Solid Biosciences Inc. (NASDAQ:SLDB) common stock. The filing identifies the triggering event date as September 30, 2026. The shares are described as being directly held by certain funds referred to in the filing as the "RTW Funds," with RTW Investments acting as the investment adviser to those funds.

The filing states that RTW Investments is a Delaware limited partnership and that Dr. Wong is a citizen of the United States. Their shared business address is listed as 40 10th Avenue, Floor 7, New York, New York 10014. The percentage of class, 5.5%, is calculated by the reporting persons based on 107,225,238 shares outstanding as of August 4, 2026, as reported in Solid Biosciences' Quarterly Report on Form 10-Q filed with the SEC on August 6, 2026.

Neither RTW Investments nor Dr. Wong reports any sole voting power or sole dispositive power over the shares. All 5,905,426 shares are attributed to shared voting power and shared dispositive power for both reporting persons. The filing notes that "the RTW Funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares reported herein." The filing also includes a certification that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

What Was Disclosed

RTW Investments, LP and Roderick Wong, M.D. disclosed a combined beneficial ownership of 5,905,426 shares, or 5.5%, of Solid Biosciences Inc. common stock via a Schedule 13G filed November 16, 2026, with a triggering event date of September 30, 2026.